Congenital generalized lipodystrophy with insulin-resistant diabetes
β Scribed by Soichi Kodama; Masato Kasuga; Atsushi Seki; Michindo Ninomiya; Takashi Sakurai; Yorihiko Morishita; Masafumi Matsuo; Tamotsu Matsuo
- Publisher
- Springer
- Year
- 1978
- Tongue
- English
- Weight
- 481 KB
- Volume
- 127
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
β¦ Synopsis
Hyperglycemia, glucose intolerance, hyperinsulinemia and resistance to exogenous insulin were found in a 10-year-old Japanese boy diagnosed as having congenital generalized lipodystrophy.
Studies on insulin receptors of circulating mononuclear leucocytes indicated that insulin-resistant diabetes combined with congenital generalized lipodystrophy may be due to disturbance of insulin binding to membrane receptors. No insulin-binding antibody or antibody that impairs insulinreceptor binding was found.
Plasma glucagon showed an exaggerated response to L-arginine before treatment. After treatment with a controlled diet and an oral sulfonylurea (500 mg/day) for 4 weeks, there was improvement in the plasma glucagon response to L-arginine. Improvement in the hyperglycemia, hyperinsulinemia and acanthosis nigricans was also observed.
On the other hand, on completion of a 7-day high-fat diet, a marked increase in serum free fatty acids, triglycerides and flqipoproteins was observed. The total plasma post-heparin lipolytic activity during the high fat diet was within the normal range. However, the level of protamine-inactivated activity was 3 times that of the control.
π SIMILAR VOLUMES
## Abstract Congenital generalised Berardinelliβseip lipodystrophy is a rare, autosomal recessive disorder characterised by selective absence of adipose tissue. Affected individuals are predisposed to severe insulin resistance and its attendant complications, including diabetes mellitus, hypertrigl
We have read with interest the paper by Guevara et al., published in a recent issue of HEPATOLOGY. 1 It is an elegant study that looked at the changes of renal and urinary parameters in 31 patients after contrast medium administration (protocol 1) and assessed the role of contrast medium as an etiol